Glycerol 3-phosphate
|
Basic information |
| Metabolite name | Glycerol 3-phosphate |
 | HMDB0000126 |
 |
C00093 |
 |
439162 |
| Synonyms | G-3-P; |
| No. of studies | 13 |
|
Basic information |
| Metabolite name | Glycerol 3-phosphate |
| HMDB0000126 |
|
C00093 |
|
439162 |
| Synonyms | G-3-P; |
| No. of studies | 13 |
|
Relationship between Glycerol 3-phosphate and depression (count: 13) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M050 | Type3 | 2h Ketamine group vs. control group | Hippocampus | C57BL/6 mouse | Up |
| Study M082 | Type3 | medium dose of DG group vs. control group | Hippocampus | C57BL/6J mouse | Down |
| Study M082 | Type3 | venlafaxine group vs. control group | Hippocampus | C57BL/6J mouse | Up |
| Study M1045 | Type1 | depression group vs. control group | Plasma | Human | Up |
| Study M1087 | Type1 | CSDS group vs. control group | Faece | C57BL/6 mouse | Up |
| Study M114 | Type3 | venlafaxine group vs. control group | Astrocyte | Sprague-Dawley rat | Up |
| Study M129 | Type3 | venlafaxine group vs. control group | Hippocampus | C57BL/6J mouse | Up |
| Study M207 | Type1 | depressed group vs. control group | Serum | Kunming mouse | Up |
| Study M460 | Type1 | depressed group vs. control group | Liver | Kunming mouse | Down |
| Study M463 | Type3 | venlafaxine group vs. control group | Prefrontal cortex | C57BL/6J mouse | Up |
| Study M671 | Type1 | CUMS group vs. control group | Striatum | Sprague-Dawley rat | Down |
| Study M755 | Type1 | high-dose D-ribose group vs. control group | Hippocampus | C57BL/6J mouse | Up |
| Study M844 | Type1 | CORT group vs. control group | PC12 cell | Rat | Up |
| Study M981 | Type2 | Abeta oligomer + acousto-optic stimulation group vs. Abeta oligomer group | Serum | ICR mouse | Up |
| Study M981 | Type2 | Abeta oligomer + involuntary and voluntary running group vs. Abeta oligomer group | Serum | ICR mouse | Up |